Catalyst Oncology

Evestia Clinical

The company provides clinical trial management and research services for pharmaceutical and biotechnology organisations developing therapies for oncology and rare diseases.

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

Oncosyne

This company develops patient-derived tumoroid drug screening platforms for pharmaceutical firms and oncologists to improve drug discovery and personalised cancer treatment.

Calithera

This pharmaceutical company develops small-molecule drugs targeting cancer metabolism and tumour immunology for healthcare providers and patients with oncology and haematology conditions.

CatalYm

This clinical-stage biotechnology company develops immunotherapies to treat solid tumours by neutralizing GDF-15 for patients with cancer therapy resistance and cachexia.

Cumulus Oncology

This company develops preclinical oncology assets and creates spin-out biotechnology firms to advance cancer treatments for pharmaceutical partners and patients.

Orakl Oncology

This company develops a predictive platform using patient tumor avatars and data to help pharmaceutical firms accelerate and de-risk cancer drug development.

BioMoti

This company develops targeted drug delivery technology for cancer therapeutics, primarily serving the pharmaceutical and biotechnology industries.